Updated on 2026/06/10

Information

 

写真a

 
TSUNEOKA YUKI
 
Organization
Kyushu University Hospital Cancer Center Assistant Professor
Kyushu University Hospital Respiratory medicine(Concurrent)
Title
Assistant Professor

Research History

  •  Kyushu University Hospital Cancer Center  Assistant Professor 

    2026.4 - Present

Papers

  • PLK1-driven cell cycle dynamics contribute to osimertinib resistance in EGFR-mutated non-small cell lung cancer Reviewed

    Tsuneoka, Y; Shibahara, D; Yonashima, Y; Otomo, K; Iwama, E; Okamoto, I

    CANCER SCIENCE   117   464 - 464   2026.1   ISSN:1347-9032 eISSN:1349-7006

     More details

  • A Case of Obstructing Bronchial Aspergillosis in a Patient Receiving Cytotoxic Chemotherapy and Inhaled Corticoid Therapy

    Tsuneoka Yuki, Okamoto Isamu, Harada Eiji, Tanaka Kentaro, Inoue Shigesato, Shimauchi Atsushi, Yoneshima Yasuto, Ikegame Satoshi

    Respiratory Endoscopy   1 ( 2 )   105 - 108   2023.11   eISSN:27583813

     More details

    Language:English   Publisher:The Japan Society for Respiratory Endoscopy  

    <p>Among various types of aspergillosis, the clinical features of patients with obstructive bronchial aspergillosis remain unclear. Originally, it was reported to occur only in severely immunocompromised patients, such as acquired immunodeficiency syndrome (AIDS) or post-organ transplantation; however, recent reports have suggested that this disease could also affect patients seen in daily practice of pulmonary medicine. We describe a case of a 76-year-old woman with obstructing bronchial aspergillosis. This patient presented to the hospital with a productive cough during asthma and advanced lung cancer treatment. Chest CT showed stenosis of the bronchial lumen. Bronchoscopy showed no recurrence of lung cancer, and aspergillus was found in the granulation tissue. The cough improved with debridement of the lesion by bronchoscopy and oral antifungal medication treatment. Our review of previous case reports, including this case, revealed that obstructing bronchial aspergillosis might occur when patients have several factors inducing immunosuppression, such as solid tumors under anticancer treatment, inhaled corticosteroids, and aging. Since patients may be at risk of progressing to invasive aspergillosis, physicians must properly diagnose obstructing bronchial aspergillosis to deliver appropriate treatment.</p>

    DOI: 10.58585/respend.2023-0020

    CiNii Research

  • 細胞傷害性化学療法と吸入コルチコイド療法を受けており閉塞性気管支アスペルギルス症を発症した1例(A Case of Obstructing Bronchial Aspergillosis in a Patient Receiving Cytotoxic Chemotherapy and Inhaled Corticoid Therapy) Reviewed

    Tsuneoka Yuki, Tanaka Kentaro, Shimauchi Atsushi, Inoue Shigesato, Yoneshima Yasuto, Ikegame Satoshi, Harada Eiji, Okamoto Isamu

    Respiratory Endoscopy   1 ( 2 )   105 - 108   2023.11

     More details

    Language:English   Publisher:(一社)日本呼吸器内視鏡学会  

    症例は77歳女性。喘息の持病があった。約5年前、慢性咳嗽の症状で当院を受診し、左肺下葉の肺腺癌(cT2aN1M0、病期IIA)と診断された。根治的放射線療法を受けたが、約2年前には肺癌が再発したため標準的な免疫化学療法(シスプラチン、ペメトレキセド、ペムブロリズマブ)と維持化学療法(ペメトレキセド+ペムブロリズマブ)が1年間行われた。本年になってから咳嗽が悪化しており、聴診所見から気管支喘息の増悪を疑って吸入皮質ステロイド療法を強化したが症状はさらに悪化した。血液検査ではアスペルギルスの抗原と特異的IgEはいずれも陰性所見であった。胸部CT画像では気管支腔の狭窄が示され、肺癌の気管支内への進行が疑われた。しかし、気管支鏡検査では肺癌の再発は認められず、代わりに左気管支の上葉支の内部に1個の白色病変が発見された。その病変の検体を採取したが、その際には抵抗を感じることなく採取することができた。その病理学的診断は閉塞性気管支アスペルギルス症とされた。白色病変のデブリードマン処置を行い、経口ボリコナゾールを開始したところ咳嗽は徐々に改善し、上昇していた白血球数とC反応性蛋白値も正常化した。6ヵ月後の気管支鏡評価では左上葉支にわずかな白色苔癬が観察されたが、生検ではアスペルギルスの菌糸は発見されなかった。そのためボリコナゾールを終了する判断をした。

  • Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: A case report Reviewed

    Egashira A., Yoneshima Y., Mizusaki S., Tsuneoka Y., Tsubouchi K., Okamoto I.

    Respiratory Medicine Case Reports   43   101845   2023.1   ISSN:2213-0071

     More details

    Language:English   Publisher:Respiratory Medicine Case Reports  

    Pleuroparenchymal fibroelastosis (PPFE) is a rare form of interstitial pneumonitis. Although most cases of PPFE are idiopathic, some cases of PPFE occur secondary to stem cell transplantation. We report a 41-year-old woman developed pneumonia after autologous peripheral blood system cell transplantation (PBSCT). Eleven years after PBSCT, she presented with dyspnea. A computed tomographic scan showed pleuroparenchymal thickening and predominantly in the upper lobes. She was diagnosed with PPFE secondary to PBSCT. She was started nintedanib and administered oxygen therapy. Most cases of PPFE secondary to stem cell transplantation have been reported. However, we experienced the case of PPFE post-autologous PBSCT.

    DOI: 10.1016/j.rmcr.2023.101845

    Scopus

    PubMed

  • 体外式膜型人工肺にて救命し得た抗ARS抗体陽性間質性肺炎の1例 Reviewed

    常岡 祐希, 河野 拓, 山下 翔, 恐田 尚幸, 河合 俊輔, 河口 知允

    日本呼吸器学会誌   11 ( 2 )   68 - 72   2022.3   ISSN:2186-5876

     More details

    Language:Japanese   Publisher:(一社)日本呼吸器学会  

    症例は49歳男性。細菌性肺炎として抗菌薬投与を行ったが改善なく人工呼吸管理を開始した。抗アミノアシルtRNA合成酵素抗体(anti aminoacyl-tRNA synthetase antibody:抗ARS抗体)陽性間質性肺炎の診断で、ステロイドパルス療法やシクロホスファミド(cyclophosphamide)パルス療法を行ったが呼吸状態は悪化、体外式膜型人工肺(extracorporeal membrane oxygenation:ECMO)を導入した。その後治療効果があり、ECMOおよび人工呼吸器は離脱した。後に免疫抑制剤減量中にCK上昇や筋症状が出現し、多発性筋炎の診断となった。急速進行した抗ARS抗体陽性間質性肺炎に対しECMOを用いて救命した1例を経験したため、文献的考察を交えて報告する。(著者抄録)

Clinician qualification

  • Specialist

    日本呼吸器学会

Year of medical license acquisition

  • 2016